In Vitro Maturation and Time-Lapse Imaging of Immature Human Oocytes: A Direction Toward Clinical Applications
- PMID: 40736789
- DOI: 10.1007/978-1-0716-4658-8_3
In Vitro Maturation and Time-Lapse Imaging of Immature Human Oocytes: A Direction Toward Clinical Applications
Abstract
Recently, multiple teams reported the successful utilization of denuded oocytes matured in vitro after controlled ovarian stimulation, as well as their small but significant contribution to cumulative live-birth rates after intracytoplasmic sperm injection (ICSI). Published data are in favor of rescue ICSI when mature oocytes are obtained one day after oocyte pickup, the clinical contribution being higher for patient with advanced maternal age, low ovarian response to COS, low maturation rate, or low fertilization rate. From a strictly resource-oriented perspective, rescue ICSI of immature oocytes may not be cost-effective as it would require additional expenses related to consumables, media, and embryologist time and as the developmental potential of such oocytes is consistently decreased across reported studies compared to their sibling mature oocytes. Being able to select the right clinical context as well as the right oocytes to fertilize to optimize outcome and resources spent is thus of significant clinical value. In that regard, even if more costly than conventional culture, time-lapse imaging may play an important role as morphokinetic markers of oocyte maturation and oocyte developmental potential have been described. However, the limited number of reported cases warrants for the restricted use of rescue ICSI only in registered clinical trials with long-term follow-up of children obtained from this still experimental procedure.
Keywords: Controlled ovarian stimulation; Germinal vesicle oocytes; ICSI; IVF; In vitro maturation; Metaphase 1 oocytes; Metaphase 2 oocytes; Rescue-ICSI; Time-lapse imaging.
© 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Abramczuk JW, Lopata A (1986) Incubator performance in the clinical in vitro fertilization program: importance of temperature conditions for the fertilization and cleavage of human oocytes*. Fertil Steril 46:132–134
-
- Aizer A, Noach-Hirsh M, Gitman H, Dratviman-Storobinsky O, Kaner Slabodnik K, Nahum R, Haas J, Orvieto R (2022) Embryos derived from delayed mature oocyte should be cryopreserved and are favourable to transfer in a following endometrium synchronize frozen-thawed cycle. Zygote 30:689–694
-
- Asama H, Kamibayashi D, Hashizume A, Michikura Y, Otsuki J (2023) Focusing on the accumulation of chromatin/chromosomes around nucleoli and optimizing the timing of ICSI to facilitate the rescue in vitro maturation of denuded GV stage oocytes. J Assist Reprod Genet 40:2557–2564
-
- Behr B, Lyon J, Litman E, Dasig D (2005) Preliminary experience comparing human recombinant hyaluronidase to bovine hyaluronidase in mouse in vitro fertilization. Fertil Steril 83:S19
-
- Belles M, Costa-Borges N, Molina JM, Ballesteros A, Pellicer A, Florensa M, Esbert M (2014) Embryo quality and clinical outcomes using EmbryoscopeTM, MincTM and HeracellTM 150i incubators: preliminary results from a randomized study with donor oocytes. Hum Reprod 29:i160
MeSH terms
LinkOut - more resources
Full Text Sources